Cryptogenic organizing pneumonia medical therapy: Difference between revisions
Sergekorjian (talk | contribs) m Sergekorjian moved page Cryptogenic organizing pneumonitis medical therapy to Cryptogenic organizing pneumonia medical therapy without leaving a redirect |
Sergekorjian (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cryptogenic organizing | {{Cryptogenic organizing pneumonia}} | ||
{{CMG}} | {{CMG}} | ||
| Line 14: | Line 14: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
Revision as of 20:24, 1 March 2016
|
Cryptogenic Organizing Pneumonia Microchapters |
|
Differentiating Cryptogenic organizing pneumonia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cryptogenic organizing pneumonia medical therapy On the Web |
|
American Roentgen Ray Society Images of Cryptogenic organizing pneumonia medical therapy |
|
Cryptogenic organizing pneumonia medical therapy in the news |
|
Directions to Hospitals Treating Cryptogenic organizing pneumonitis |
|
Risk calculators and risk factors for Cryptogenic organizing pneumonia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
About two thirds of patients recover with corticosteroid therapy. Prednisolone is often administered in Europe and prednisone in the USA. These two compounds differ by only one functional group and have the same clinical effect. The steroid is initially administered at high doses, typically 50 mg per day tapering down to zero over a 6 month to one year period. If the steroid treatment is halted too quickly the disease may return.